Taipei Medical University Makes New Breakthrough in AI Medicine: Screening of Cancer Risks through Blood Samples Becomes Possible

Source: College of Medical Science and Technology

Published on 2020-08-24

An international research team led by Taipei Medical University employed artificial intelligence (AI) in the identifying of high cancer risk groups through blood data obtained from general health examinations.


The study was published on Scientific Reports, a journal published by Nature Research, on March 16, 2020.

This research, said Shabbir Syed Abdul, an associate professor at the Graduate Institute of Biomedical Informatics of Taipei Medical University, had been mainly conducted through AI, employing machine learning algorithms in the screening of cell population data (CPD) for hematologic malignancies. The research team collected a total of 882 hematology-oncology cases from Konkuk University Medical Center, Seoul, South Korea, among which 457 cases were of hematologic malignancies and 425 cases were of hematologic non-malignancies. Then seven models, including SGD, SVM, ANN, linear model, and logistic regression, were employed in AI learning. AI was further used to screen the data obtained from the blood samples collected from the hematology-oncology case subjects; the highest diagnosis rate of 93.5% was achieved by ANN.

Associate Professor Shabbir Syed Abdul from India has successfully acquired the Alien Permanent Resident Card of Taiwan, the “Plum Blossom Card” in 2017 in recognition of his outstanding research performance

The study has been jointly participated by South Korea, Slovenia, and Saudi Arabia. Associate Professor Shabbir Syed Abdul explained that as blood cancer is harder to diagnose than other cancers and usually requires the combination of blood smear and bone marrow smear examinations, many cancer patients are often diagnosed when the cancer had already progressed to the middle or advanced stages, resulting in missed optimal treatment timings. The new screening method can facilitate early risk detection through blood tests in routine health examinations of patients and timely responses, demonstrating promising research results.

 Did you know?

The results of the study will enable medical facilities to detect the risk levels of the future development of hematologic malignancies, such as lymphoma and blood cancer, through blood test data and AI analysis without the requirement of additional examinations, reducing costs of human resources, medical expenses, time, etc. Moreover, as early diagnoses and treatments can be achieved, the effects on the lowering of cancer mortality rates are highly anticipated.

This article is simultaneously available on QS WOWNews.

Taipei Medical University COVID-19 Special Report: 2020 Wrap-Up

Taipei Medical University (TMU) are blessed to be able to carry on with our core activities in learning and research. And, besides being one of Taiwan’s best medical education providers, TMU is interwoven with the country’s many successes in fighting the pandemic.

Taipei Medical University Feng-Hsing Sociomedical and Medical Knowledge Promotion Service Group’s decade of service in Penghu, an island in Taiwan

The year 2020 will mark TMU Feng-Hsing Sociomedical and Medical Knowledge Promotion Service Group's (臺北醫學大楓杏醫療志工學生服務隊) (abbrev. TMU Feng-Hsing) 10th year of volunteer clinic service in Penghu.

Taipei Medical University students engaging in service learning in a mountain indigenous township despite epidemic and storm

The College of Nutrition, the Graduate Institute of Humanities in Medicine and the School of Pharmacy work together to lead students in service learning in Jianshi Township (尖石鄉), a mountain indigenous township in Hsinchu County in northern Taiwan, despite epidemic and storm.

Taipei Medical University establishing “OHDSI Taiwan Chapter,” joining global transnational research published in JAMIA

In collaboration with the Observational Health Data Sciences and Informatics (OHDSI), Taipei Medical University (TMU) established “OHDSI Taiwan Chapter” and participated in the "Uncovering exposures responsible for birth season– disease effects," a global research conducted by experts and scholars from Taiwan, the US, South Korea and other countries.

Taipei Medical University Celebrates 60 Years of Excellence

Taipei Medical University (TMU) celebrated the 60th anniversary of founding on October 30, 2020, with more than 450 dignitaries, professors, students and alumni joining the diamond jubilee.

2020 Taipei Medical University Oral Medical Service Teams Visited Rural Areas

In 2020, TMU College of Oral Medicine sent three medical service teams, comprised of faculty members and students, to visit remote areas in Taiwan.